Glaxosmithkline Drug Patent Portfolio

Glaxosmithkline owns 20 orange book drugs protected by 127 US patents with Bactroban having the least patent protection, holding only 2 patents. And Ventolin Hfa with maximum patent protection, holding 35 patents. Given below is the list of Glaxosmithkline's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11963962 Platelet count-agnostic methods of treating myelofibrosis 02 Dec, 2040
Active
US11730725 Niraparib formulations 04 Jan, 2039
Active
US11091459 Niraparib compositions 27 Mar, 2038
Active
US11673877 Niraparib compositions 27 Mar, 2038
Active
US11117871 Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof 13 Mar, 2038
Active
US11649217 Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof 13 Mar, 2038
Active
US9809559 (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide 11 Jun, 2035
Active
USRE48285 N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide 11 Jun, 2035
Active
US8859562 Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer 04 Aug, 2031
Active
US8746242 Medicament dispenser 11 Apr, 2031
Active
US8071623 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors 27 Mar, 2031
Active
US11090294 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist 29 Nov, 2030
Active
US9750726 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist 29 Nov, 2030
Active
US8746242 Medicament dispenser 11 Oct, 2030
Active
US8534281 Manifold for use in medicament dispenser 08 Sep, 2030
Active
US8534281 Manifold for use in medicament dispenser 08 Mar, 2030
Active
US8486941 Phenyl amino pyrimidine compounds and uses thereof 03 Jan, 2030
Active
US8436185 Pharmaceutically acceptable salts of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide 24 Apr, 2029
Active
US8201556 Medicament dispenser 05 Feb, 2029
Active
US8324208 Prolyl hydroxylase inhibitors 11 Dec, 2028
Active
US8161968 Medicament dispenser 05 Aug, 2028
Active
US8113199 Counter for use with a medicament dispenser 23 Apr, 2028
Active
US9333310 Medicament dispenser 02 Apr, 2028
Active
US8161968 Medicament dispenser 05 Feb, 2028
Active
US7488827 Muscarinic acetylcholine receptor antagonists 18 Dec, 2027
Active
US8511304 Medicament dispenser 14 Dec, 2027
Active
US8113199 Counter for use with a medicament dispenser 23 Oct, 2027
Active
US9333310 Medicament dispenser 02 Oct, 2027
Active
US8071579 DNA damage repair inhibitors for the treatment of cancer 12 Aug, 2027
Active
US8143241 DNA damage repair inhibitors for treatment of cancer 12 Aug, 2027
Active
US11643397 Prolyl hydroxylase inhibitors 22 Jun, 2027
Active
US8557834 Prolyl hydroxylase inhibitors 22 Jun, 2027
Active
US8815884 Prolyl hydroxylase inhibitors 22 Jun, 2027
Active
US8511304 Medicament dispenser 14 Jun, 2027
Active
US8347879 Fluid dispensing device 01 Apr, 2027
Active
US8062264 Fluid dispensing device 05 Apr, 2026
Active
US8752543 Fluid dispensing device 05 Apr, 2026
Active
US7439393 Phenethanolamine derivatives for treatment of respiratory diseases 21 Nov, 2025
Active
US8183257 Muscarinic acetylcholine receptor antagonists 27 Jul, 2025
Active
US7500444 Actuation indicator for a dispensing device 04 Jul, 2025
Active
US7439393 Phenethanolamine derivatives for treatment of respiratory diseases 21 May, 2025
Active
US7498440 Muscarinic acetylcholine receptor antagonists 27 Apr, 2025
Active
US8309572 Muscarinic acetylcholine receptor antagonists 27 Apr, 2025
Active
US8147461 Fluid dispensing device 10 Mar, 2025
Active
US7500444 Actuation indicator for a dispensing device 04 Jan, 2025
Active
US9320862 Fluid dispensing device 06 Nov, 2024
Active
US7832351 Actuation indicator for a dispensing device 19 Dec, 2023 Expired
US7832351 Actuation indicator for a dispensing device 19 Jun, 2023 Expired
US7361787 Phenethanolamine derivatives for treatment of respiratory diseases 23 Mar, 2023 Expired
USRE44874 Phenethanolamine derivatives for treatment of respiratory diseases 23 Mar, 2023 Expired
US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases 11 Sep, 2022 Expired
US6743413 Suspension aerosol formulations 01 Dec, 2021 Expired
US7101866 Anti-inflammatory androstane derivative 03 Aug, 2021 Expired
US7629335 Anti-inflammatory androstane derivative 03 Aug, 2021 Expired
US6537983 Anti-inflammatory androstane derivatives 03 Aug, 2021 Expired
US6759398 Anti-inflammatory androstane derivative 03 Aug, 2021 Expired
US6878698 Anti-inflammatory androstane derivatives 03 Aug, 2021 Expired
US6858596 Formulation containing anti-inflammatory androstane derivative 03 Aug, 2021 Expired
US7541350 Formulation containing anti-inflammatory androstane derivative 03 Aug, 2021 Expired
US6743413 Suspension aerosol formulations 01 Jun, 2021 Expired
US9861771 Device housing for an aerosol container 11 Oct, 2020 Expired
US7350676 Valve for aerosol container 24 Feb, 2019 Expired
US6431168 Dispenser with doses′ counter 08 Dec, 2018 Expired
US7107986 Dispenser with doses' counter 06 Dec, 2018 Expired
US6004968 Pharmaceutical compositions containing lamivudine 20 Sep, 2018 Expired
US7350676 Valve for aerosol container 24 Aug, 2018 Expired
US6161724 Indicating device 16 Jul, 2018 Expired
US6435372 Delivery system for a medicament and method for the assembly thereof 16 Jul, 2018 Expired
US6938796 Indicating device 16 Jul, 2018 Expired
US6997349 Indicating device 16 Jul, 2018 Expired
US7143908 Indicating device 16 Jul, 2018 Expired
US6170717 Valve for aerosol container 23 Jun, 2018 Expired
US6315173 Valve for aerosol container 23 Jun, 2018 Expired
US6510969 Valve for aerosol container 23 Jun, 2018 Expired
US6966467 Valve for aerosol container 23 Jun, 2018 Expired
US6431168 Dispenser with doses′ counter 08 Jun, 2018 Expired
US7107986 Dispenser with doses' counter 08 Jun, 2018 Expired
US6004968 Pharmaceutical compositions containing lamivudine 20 Mar, 2018 Expired
US6161724 Indicating device 16 Jan, 2018 Expired
US6435372 Delivery system for a medicament and method for the assembly thereof 16 Jan, 2018 Expired
US6938796 Indicating device 16 Jan, 2018 Expired
US6997349 Indicating device 16 Jan, 2018 Expired
US7143908 Indicating device 16 Jan, 2018 Expired
US6170717 Valve for aerosol container 23 Dec, 2017 Expired
US6315173 Valve for aerosol container 23 Dec, 2017 Expired
US6510969 Valve for aerosol container 23 Dec, 2017 Expired
US6966467 Valve for aerosol container 23 Dec, 2017 Expired
US6730679 Pharmaceutical formulations 11 Nov, 2017 Expired
US6558651 Aerosols containing annealed particulate salbutamol and tetrafluoroethane 19 Jun, 2017 Expired
US6558651 Aerosols containing annealed particulate salbutamol and tetrafluoroethane 19 Dec, 2016 Expired
US5905082 Crystalline oxathiolane derivatives 18 Nov, 2016 Expired
US5873360 Inhalation device 23 Aug, 2016 Expired
US5879706 Valaciclovir tablets containing colloidal silicon dioxide 19 Jul, 2016 Expired
US6107302 Guanine derivative 19 Jul, 2016 Expired
US5905082 Crystalline oxathiolane derivatives 18 May, 2016 Expired
US5873360 Inhalation device 23 Feb, 2016 Expired
US5879706 Valaciclovir tablets containing colloidal silicon dioxide 19 Jan, 2016 Expired
US6107302 Guanine derivative 19 Jan, 2016 Expired
US5723490 THF-containing sulfonamide inhibitors of aspartyl protease 03 Mar, 2015 Expired
US6596260 Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol 10 Feb, 2015 Expired
US6294572 Crystalline N-acetyl neuraminic acid derivatives and process for their preparation 15 Dec, 2014 Expired
US6025389 Pharmaceutical and veterinary compositions of mupirocin and methods for their preparation 20 Oct, 2014 Expired
US6596260 Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol 10 Aug, 2014 Expired
US5648379 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents 15 Jul, 2014 Expired
US5646180 Treatment of the CNS effects of HIV 08 Jul, 2014 Expired
US5998449 Combination of atovaquone with proguanil for the treatment of protozoal infections 25 May, 2014 Expired
US6166046 Combination of atovaquone with proguanil for the treatment of protozoal infections 25 May, 2014 Expired
US6291488 Preventing protozoal infections 25 May, 2014 Expired
US5629297 Medicament for treating gastrointestinal disorders 13 May, 2014 Expired
US5554639 Medicaments 10 Mar, 2014 Expired
US5601848 Methods for the treatment of gastrointestinal disorders 11 Feb, 2014 Expired
USRE39155 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B 02 Jan, 2014 Expired
US5585397 Sulfonamide inhibitors of aspartyl protease 17 Dec, 2013 Expired
US5998449 Combination of atovaquone with proguanil for the treatment of protozoal infections 25 Nov, 2013 Expired
US6166046 Combination of atovaquone with proguanil for the treatment of protozoal infections 25 Nov, 2013 Expired
US6291488 Preventing protozoal infections 25 Nov, 2013 Expired
US5569672 Compounds 29 Oct, 2013 Expired
US5554639 Medicaments 10 Sep, 2013 Expired
US5358970 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer 12 Aug, 2013 Expired
US5427798 Controlled sustained release tablets containing bupropion 12 Aug, 2013 Expired
US5731000 Stabilized pharmaceutical composition containing bupropion 12 Aug, 2013 Expired
US5763493 Stabilized pharmaceutical 12 Aug, 2013 Expired
US5360817 Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents 26 Jul, 2013 Expired
USRE39155 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B 02 Jul, 2013 Expired
US5307953 Single dose dispenser having a piercing member 02 Jun, 2013 Expired
US5307953 Single dose dispenser having a piercing member 02 Dec, 2012 Expired
US5456925 Pharmaceutical compositions containing furan derivatives 10 Oct, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Glaxosmithkline.

Activity Date Patent Number
Patent litigations
Second letter to regulating agency to determine regulatory review period 26 Apr, 2024 US8324208
Payment of Maintenance Fee, 12th Year, Large Entity 19 Apr, 2024 US8309572
Email Notification 13 Feb, 2024 US11730725
Mail Pet Dec Routed to Certificate of Corrections Branch 12 Feb, 2024 US11730725
Mail-Record a Petition Decision of Granted for Patent Term Adjustment after Issue 12 Feb, 2024 US11730725
Record a Petition Decision of Granted for Patent Term Adjustment after Issue 09 Feb, 2024 US11730725
Pet Dec Routed to Certificate of Corrections Branch 09 Feb, 2024 US11730725
Adjustment of PTA Calculation by PTO 09 Feb, 2024 US11730725
Second letter to regulating agency to determine regulatory review period 08 Feb, 2024 US8486941
Letter from FDA or Dept of Agriculture re PTE application 30 Jan, 2024 US8324208
Letter from FDA or Dept of Agriculture re PTE application 30 Jan, 2024 US8486941
Payment of Maintenance Fee, 12th Year, Large Entity 21 Nov, 2023 US8201556
Payment of Maintenance Fee, 12th Year, Large Entity 21 Nov, 2023 US8201556
Initial letter Re: PTE Application to regulating agency 17 Nov, 2023 US8486941
Change in Power of Attorney (May Include Associate POA) 01 Nov, 2023 US8486941


Glaxosmithkline's Drug Patent Litigations

Glaxosmithkline's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jul 26, 2001, against patent number US6596260. The petitioner , challenged the validity of this patent, with BRUGGER et al as the respondent. Click below to track the latest information on how companies are challenging Glaxosmithkline's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US6743413 September, 2015 Terminated-Settled
(18 Nov, 2016)
3M Company Mylan Pharmaceuticals Inc.
US8859562 October, 2011 Decision
(25 Mar, 2014)
Thomas Helleday
US6596260 July, 2001 Decision
(25 Sep, 2002)
BRUGGER et al


Glaxosmithkline Drug Patents' Oppositions Filed in EPO

Glaxosmithkline drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Apr 13, 2012, by Strawman Limited. This opposition was filed on patent number EP04743564A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP06765149A Apr, 2020 ELKINGTON AND FIFE LLP Patent maintained as amended
EP10781527A Sep, 2018 Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. Granted and Under Opposition
EP10781527A Sep, 2018 Breuer, Markus Granted and Under Opposition
EP10781527A Sep, 2018 Teva UK Limited Granted and Under Opposition
EP10178947A Jun, 2015 Teva UK Limited Revoked
EP03731693A May, 2014 Teva UK Limited Opposition rejected
EP03731693A May, 2014 Vossius & Partner Opposition rejected
EP04798705A May, 2012 Adams, Harvey Vaughan John Opposition procedure closed
EP04798705A May, 2012 STRAWMAN LIMITED Opposition procedure closed
EP04743564A Apr, 2012 Adams, Harvey Vaughan John Patent maintained as amended
EP04743564A Apr, 2012 STRAWMAN LIMITED Patent maintained as amended


Glaxosmithkline's Family Patents

Glaxosmithkline drugs have patent protection in a total of 56 countries. It's US patent count contributes only to 14.0% of its total global patent coverage. 9 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Glaxosmithkline Drug List

Given below is the complete list of Glaxosmithkline's drugs and the patents protecting them.


1. Agenerase

Agenerase is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6730679 Pharmaceutical formulations 11 Nov, 2017
(6 years ago)
Expired
US5723490 THF-containing sulfonamide inhibitors of aspartyl protease 03 Mar, 2015
(9 years ago)
Expired
US5646180 Treatment of the CNS effects of HIV 08 Jul, 2014
(10 years ago)
Expired
US5585397 Sulfonamide inhibitors of aspartyl protease 17 Dec, 2013
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Agenerase's drug page


2. Anoro Ellipta

Anoro Ellipta is protected by 25 patents, out of which 4 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8746242
(Pediatric)
Medicament dispenser 11 Apr, 2031
(6 years from now)
Active
US11090294 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist 29 Nov, 2030
(6 years from now)
Active
US9750726 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist 29 Nov, 2030
(6 years from now)
Active
US8746242 Medicament dispenser 11 Oct, 2030
(6 years from now)
Active
US8534281
(Pediatric)
Manifold for use in medicament dispenser 08 Sep, 2030
(5 years from now)
Active
US8534281 Manifold for use in medicament dispenser 08 Mar, 2030
(5 years from now)
Active
US8201556 Medicament dispenser 05 Feb, 2029
(4 years from now)
Active
US8161968
(Pediatric)
Medicament dispenser 05 Aug, 2028
(3 years from now)
Active
US8113199
(Pediatric)
Counter for use with a medicament dispenser 23 Apr, 2028
(3 years from now)
Active
US9333310
(Pediatric)
Medicament dispenser 02 Apr, 2028
(3 years from now)
Active
US8161968 Medicament dispenser 05 Feb, 2028
(3 years from now)
Active
US7488827 Muscarinic acetylcholine receptor antagonists 18 Dec, 2027
(3 years from now)
Active
US8511304
(Pediatric)
Medicament dispenser 14 Dec, 2027
(3 years from now)
Active
US8113199 Counter for use with a medicament dispenser 23 Oct, 2027
(3 years from now)
Active
US9333310 Medicament dispenser 02 Oct, 2027
(2 years from now)
Active
US8511304 Medicament dispenser 14 Jun, 2027
(2 years from now)
Active
US7439393
(Pediatric)
Phenethanolamine derivatives for treatment of respiratory diseases 21 Nov, 2025
(1 year, 1 month from now)
Active
US8183257 Muscarinic acetylcholine receptor antagonists 27 Jul, 2025
(9 months from now)
Active
US7439393 Phenethanolamine derivatives for treatment of respiratory diseases 21 May, 2025
(7 months from now)
Active
US7498440 Muscarinic acetylcholine receptor antagonists 27 Apr, 2025
(6 months from now)
Active
US8309572 Muscarinic acetylcholine receptor antagonists 27 Apr, 2025
(6 months from now)
Active
US7361787 Phenethanolamine derivatives for treatment of respiratory diseases 23 Mar, 2023
(1 year, 6 months ago)
Expired
USRE44874 Phenethanolamine derivatives for treatment of respiratory diseases 23 Mar, 2023
(1 year, 6 months ago)
Expired
US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases 11 Sep, 2022
(2 years ago)
Expired
US5873360 Inhalation device 23 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Anoro Ellipta's drug page


3. Arnuity Ellipta

Arnuity Ellipta is protected by 14 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8746242
(Pediatric)
Medicament dispenser 11 Apr, 2031
(6 years from now)
Active
US8746242 Medicament dispenser 11 Oct, 2030
(6 years from now)
Active
US8534281
(Pediatric)
Manifold for use in medicament dispenser 08 Sep, 2030
(5 years from now)
Active
US8534281 Manifold for use in medicament dispenser 08 Mar, 2030
(5 years from now)
Active
US8201556 Medicament dispenser 05 Feb, 2029
(4 years from now)
Active
US8161968
(Pediatric)
Medicament dispenser 05 Aug, 2028
(3 years from now)
Active
US8113199
(Pediatric)
Counter for use with a medicament dispenser 23 Apr, 2028
(3 years from now)
Active
US9333310
(Pediatric)
Medicament dispenser 02 Apr, 2028
(3 years from now)
Active
US8161968 Medicament dispenser 05 Feb, 2028
(3 years from now)
Active
US8113199 Counter for use with a medicament dispenser 23 Oct, 2027
(3 years from now)
Active
US9333310 Medicament dispenser 02 Oct, 2027
(2 years from now)
Active
US7101866 Anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired
US7629335 Anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired
US5873360 Inhalation device 23 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Arnuity Ellipta's drug page


4. Bactroban

Bactroban is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6025389 Pharmaceutical and veterinary compositions of mupirocin and methods for their preparation 20 Oct, 2014
(9 years ago)
Expired
US5569672 Compounds 29 Oct, 2013
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Bactroban's drug page


5. Epivir-hbv

Epivir-hbv is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6004968
(Pediatric)
Pharmaceutical compositions containing lamivudine 20 Sep, 2018
(6 years ago)
Expired
US6004968 Pharmaceutical compositions containing lamivudine 20 Mar, 2018
(6 years ago)
Expired
US5905082
(Pediatric)
Crystalline oxathiolane derivatives 18 Nov, 2016
(7 years ago)
Expired
US5905082 Crystalline oxathiolane derivatives 18 May, 2016
(8 years ago)
Expired
USRE39155
(Pediatric)
Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B 02 Jan, 2014
(10 years ago)
Expired
USRE39155 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B 02 Jul, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Epivir-hbv's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Imitrex

Imitrex is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5554639
(Pediatric)
Medicaments 10 Mar, 2014
(10 years ago)
Expired
US5554639 Medicaments 10 Sep, 2013
(11 years ago)
Expired
US5307953
(Pediatric)
Single dose dispenser having a piercing member 02 Jun, 2013
(11 years ago)
Expired
US5307953 Single dose dispenser having a piercing member 02 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Imitrex's drug page


7. Jesduvroq

Jesduvroq is protected by 6 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11117871 Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof 13 Mar, 2038
(13 years from now)
Active
US11649217 Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof 13 Mar, 2038
(13 years from now)
Active
US8324208 Prolyl hydroxylase inhibitors 11 Dec, 2028
(4 years from now)
Active
US11643397 Prolyl hydroxylase inhibitors 22 Jun, 2027
(2 years from now)
Active
US8557834 Prolyl hydroxylase inhibitors 22 Jun, 2027
(2 years from now)
Active
US8815884 Prolyl hydroxylase inhibitors 22 Jun, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jesduvroq's drug page


8. Malarone

Malarone is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5998449
(Pediatric)
Combination of atovaquone with proguanil for the treatment of protozoal infections 25 May, 2014
(10 years ago)
Expired
US6166046
(Pediatric)
Combination of atovaquone with proguanil for the treatment of protozoal infections 25 May, 2014
(10 years ago)
Expired
US6291488
(Pediatric)
Preventing protozoal infections 25 May, 2014
(10 years ago)
Expired
US5998449 Combination of atovaquone with proguanil for the treatment of protozoal infections 25 Nov, 2013
(10 years ago)
Expired
US6166046 Combination of atovaquone with proguanil for the treatment of protozoal infections 25 Nov, 2013
(10 years ago)
Expired
US6291488 Preventing protozoal infections 25 Nov, 2013
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Malarone's drug page


9. Malarone Pediatric

Malarone Pediatric is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5998449
(Pediatric)
Combination of atovaquone with proguanil for the treatment of protozoal infections 25 May, 2014
(10 years ago)
Expired
US6166046
(Pediatric)
Combination of atovaquone with proguanil for the treatment of protozoal infections 25 May, 2014
(10 years ago)
Expired
US6291488
(Pediatric)
Preventing protozoal infections 25 May, 2014
(10 years ago)
Expired
US5998449 Combination of atovaquone with proguanil for the treatment of protozoal infections 25 Nov, 2013
(10 years ago)
Expired
US6166046 Combination of atovaquone with proguanil for the treatment of protozoal infections 25 Nov, 2013
(10 years ago)
Expired
US6291488 Preventing protozoal infections 25 Nov, 2013
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Malarone Pediatric's drug page


10. Ojjaara

Ojjaara is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11963962 Platelet count-agnostic methods of treating myelofibrosis 02 Dec, 2040
(16 years from now)
Active
US9809559 (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide 11 Jun, 2035
(10 years from now)
Active
USRE48285 N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide 11 Jun, 2035
(10 years from now)
Active
US8486941 Phenyl amino pyrimidine compounds and uses thereof 03 Jan, 2030
(5 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ojjaara's drug page


11. Relenza

Relenza is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6294572 Crystalline N-acetyl neuraminic acid derivatives and process for their preparation 15 Dec, 2014
(9 years ago)
Expired
US5648379 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents 15 Jul, 2014
(10 years ago)
Expired
US5360817 Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents 26 Jul, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Relenza's drug page


12. Serevent

Serevent is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5873360
(Pediatric)
Inhalation device 23 Aug, 2016
(8 years ago)
Expired
US5873360 Inhalation device 23 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Serevent's drug page


13. Trelegy Ellipta

Trelegy Ellipta is protected by 27 patents, out of which 7 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8746242
(Pediatric)
Medicament dispenser 11 Apr, 2031
(6 years from now)
Active
US11090294 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist 29 Nov, 2030
(6 years from now)
Active
US9750726 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist 29 Nov, 2030
(6 years from now)
Active
US8746242 Medicament dispenser 11 Oct, 2030
(6 years from now)
Active
US8534281
(Pediatric)
Manifold for use in medicament dispenser 08 Sep, 2030
(5 years from now)
Active
US8534281 Manifold for use in medicament dispenser 08 Mar, 2030
(5 years from now)
Active
US8161968
(Pediatric)
Medicament dispenser 05 Aug, 2028
(3 years from now)
Active
US8113199
(Pediatric)
Counter for use with a medicament dispenser 23 Apr, 2028
(3 years from now)
Active
US9333310
(Pediatric)
Medicament dispenser 02 Apr, 2028
(3 years from now)
Active
US8161968 Medicament dispenser 05 Feb, 2028
(3 years from now)
Active
US7488827 Muscarinic acetylcholine receptor antagonists 18 Dec, 2027
(3 years from now)
Active
US8511304
(Pediatric)
Medicament dispenser 14 Dec, 2027
(3 years from now)
Active
US8113199 Counter for use with a medicament dispenser 23 Oct, 2027
(3 years from now)
Active
US9333310 Medicament dispenser 02 Oct, 2027
(2 years from now)
Active
US8511304 Medicament dispenser 14 Jun, 2027
(2 years from now)
Active
US7439393
(Pediatric)
Phenethanolamine derivatives for treatment of respiratory diseases 21 Nov, 2025
(1 year, 1 month from now)
Active
US8183257 Muscarinic acetylcholine receptor antagonists 27 Jul, 2025
(9 months from now)
Active
US7439393 Phenethanolamine derivatives for treatment of respiratory diseases 21 May, 2025
(7 months from now)
Active
US7498440 Muscarinic acetylcholine receptor antagonists 27 Apr, 2025
(6 months from now)
Active
US8309572 Muscarinic acetylcholine receptor antagonists 27 Apr, 2025
(6 months from now)
Active
USRE44874 Phenethanolamine derivatives for treatment of respiratory diseases 23 Mar, 2023
(1 year, 6 months ago)
Expired
US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases 11 Sep, 2022
(2 years ago)
Expired
US6537983 Anti-inflammatory androstane derivatives 03 Aug, 2021
(3 years ago)
Expired
US6759398 Anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired
US6878698 Anti-inflammatory androstane derivatives 03 Aug, 2021
(3 years ago)
Expired
US7101866 Anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired
US7629335 Anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Trelegy Ellipta's drug page


14. Tritec

Tritec is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5629297 Medicament for treating gastrointestinal disorders 13 May, 2014
(10 years ago)
Expired
US5601848 Methods for the treatment of gastrointestinal disorders 11 Feb, 2014
(10 years ago)
Expired
US5456925 Pharmaceutical compositions containing furan derivatives 10 Oct, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tritec's drug page


15. Valtrex

Valtrex is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5879706
(Pediatric)
Valaciclovir tablets containing colloidal silicon dioxide 19 Jul, 2016
(8 years ago)
Expired
US6107302
(Pediatric)
Guanine derivative 19 Jul, 2016
(8 years ago)
Expired
US5879706 Valaciclovir tablets containing colloidal silicon dioxide 19 Jan, 2016
(8 years ago)
Expired
US6107302 Guanine derivative 19 Jan, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Valtrex's drug page


16. Ventolin Hfa

Ventolin Hfa is protected by 35 patents, out of which 33 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7500444
(Pediatric)
Actuation indicator for a dispensing device 04 Jul, 2025
(8 months from now)
Active
US7500444 Actuation indicator for a dispensing device 04 Jan, 2025
(2 months from now)
Active
US7832351
(Pediatric)
Actuation indicator for a dispensing device 19 Dec, 2023
(9 months ago)
Expired
US7832351 Actuation indicator for a dispensing device 19 Jun, 2023
(1 year, 3 months ago)
Expired
US6743413
(Pediatric)
Suspension aerosol formulations 01 Dec, 2021
(2 years ago)
Expired
US6743413 Suspension aerosol formulations 01 Jun, 2021
(3 years ago)
Expired
US9861771 Device housing for an aerosol container 11 Oct, 2020
(4 years ago)
Expired
US7350676
(Pediatric)
Valve for aerosol container 24 Feb, 2019
(5 years ago)
Expired
US6431168
(Pediatric)
Dispenser with doses′ counter 08 Dec, 2018
(5 years ago)
Expired
US7107986
(Pediatric)
Dispenser with doses' counter 06 Dec, 2018
(5 years ago)
Expired
US7350676 Valve for aerosol container 24 Aug, 2018
(6 years ago)
Expired
US6161724
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US6435372
(Pediatric)
Delivery system for a medicament and method for the assembly thereof 16 Jul, 2018
(6 years ago)
Expired
US6938796
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US6997349
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US7143908
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US6170717
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6315173
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6510969
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6966467
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6431168 Dispenser with doses′ counter 08 Jun, 2018
(6 years ago)
Expired
US7107986 Dispenser with doses' counter 08 Jun, 2018
(6 years ago)
Expired
US6161724 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US6435372 Delivery system for a medicament and method for the assembly thereof 16 Jan, 2018
(6 years ago)
Expired
US6938796 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US6997349 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US7143908 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US6170717 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US6315173 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US6510969 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US6966467 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US6558651
(Pediatric)
Aerosols containing annealed particulate salbutamol and tetrafluoroethane 19 Jun, 2017
(7 years ago)
Expired
US6558651 Aerosols containing annealed particulate salbutamol and tetrafluoroethane 19 Dec, 2016
(7 years ago)
Expired
US6596260
(Pediatric)
Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol 10 Feb, 2015
(9 years ago)
Expired
US6596260 Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol 10 Aug, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ventolin Hfa's drug page


17. Veramyst

Veramyst is protected by 8 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8347879 Fluid dispensing device 01 Apr, 2027
(2 years from now)
Active
US8062264 Fluid dispensing device 05 Apr, 2026
(1 year, 5 months from now)
Active
US8752543 Fluid dispensing device 05 Apr, 2026
(1 year, 5 months from now)
Active
US8147461 Fluid dispensing device 10 Mar, 2025
(4 months from now)
Active
US9320862 Fluid dispensing device 06 Nov, 2024
(26 days from now)
Active
US6858596 Formulation containing anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired
US7101866 Anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired
US7541350 Formulation containing anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Veramyst's drug page


18. Wellbutrin Sr

Wellbutrin Sr is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5358970 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer 12 Aug, 2013
(11 years ago)
Expired
US5427798 Controlled sustained release tablets containing bupropion 12 Aug, 2013
(11 years ago)
Expired
US5731000 Stabilized pharmaceutical composition containing bupropion 12 Aug, 2013
(11 years ago)
Expired
US5763493 Stabilized pharmaceutical 12 Aug, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Wellbutrin Sr's drug page


19. Zejula

Zejula is protected by 8 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11730725 Niraparib formulations 04 Jan, 2039
(14 years from now)
Active
US11091459 Niraparib compositions 27 Mar, 2038
(13 years from now)
Active
US11673877 Niraparib compositions 27 Mar, 2038
(13 years from now)
Active
US8859562 Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer 04 Aug, 2031
(6 years from now)
Active
US8071623 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors 27 Mar, 2031
(6 years from now)
Active
US8436185 Pharmaceutically acceptable salts of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide 24 Apr, 2029
(4 years from now)
Active
US8071579 DNA damage repair inhibitors for the treatment of cancer 12 Aug, 2027
(2 years from now)
Active
US8143241 DNA damage repair inhibitors for treatment of cancer 12 Aug, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zejula's drug page


20. Zyban

Zyban is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5358970 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer 12 Aug, 2013
(11 years ago)
Expired
US5427798 Controlled sustained release tablets containing bupropion 12 Aug, 2013
(11 years ago)
Expired
US5731000 Stabilized pharmaceutical composition containing bupropion 12 Aug, 2013
(11 years ago)
Expired
US5763493 Stabilized pharmaceutical 12 Aug, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zyban's drug page